✦ LIBER ✦

GDF-15 FOR RISK STRATIFICATION IN ATRIAL FIBRILLATION TREATED WITH APIXABAN OR WARFARIN: INSIGHTS FROM THE ARISTOTLE TRIAL

✍ Scribed by Wallentin, Lars; Andersson, Ulrika

Book ID: 122281846
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 235 KB
Volume: 63
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(14)60361-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apixaban in patients with atrial fibrill

Apixaban in patients with atrial fibrillation and prior coronary artery disease: Insights from the ARISTOTLE trial

✍ Bahit, Maria Cecilia; Lopes, Renato D.; Wojdyla, Daniel M.; Hohnloser, Stefan H. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 291 KB

Apixaban compared with warfarin in patie

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

✍ J Donald Easton; Renato D Lopes; M Cecilia Bahit; Daniel M Wojdyla; Christopher 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 264 KB

Efficacy and Safety of Apixaban Compared

Efficacy and Safety of Apixaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation from East Asia: A Subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

✍ Goto, Shinya; Zhu, Jun; Liu, Lisheng; Oh, Byung-Hee; Wojdyla, Daniel M.; Aylward 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 356 KB

Bleeding During Treatment With Aspirin V

Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin: The Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) Trial

✍ Flaker, G. C.; Eikelboom, J. W.; Shestakovska, O.; Connolly, S. J.; Kaatz, S.; B 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 850 KB

900 Efficacy and safety of apixaban comp

900 Efficacy and safety of apixaban compared to warfarin for prevention of stroke and systemic embolism in 18,201 patients with atrial fibrillation: Primary results of the ARISTOTLE Trial

✍ J. Ezekowitz; P. Dorian; C. Granger; J. Alexander; R. Lopes; M. Hanna; M. Gerald 📂 Article 📅 2011 🏛 Pulsus Group Inc 🌐 English ⚖ 72 KB

POORLY CONTROLLED BLOOD PRESSURE IS INDE

POORLY CONTROLLED BLOOD PRESSURE IS INDEPENDENTLY ASSOCIATED WITH A 50% HIGHER RISK OF STROKE OR SYSTEMIC EMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION: RESULTS FROM THE ARISTOTLE TRIAL

✍ Rao, Meena; Halvorsen, Sigrun; Wojdyla, Daniel; Alexander, John; Lopes, Renato; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 235 KB